Piramal Pharma Ltd
NSE:PPLPHARMA
Cash Flow Statement
Cash Flow Statement
Piramal Pharma Ltd
Mar-2024 | Sep-2024 | ||
---|---|---|---|
Operating Cash Flow | |||
Net Income |
1 198
|
0
|
|
Depreciation & Amortization |
7 406
|
0
|
|
Other Non-Cash Items |
5 353
|
0
|
|
Cash Taxes Paid |
1 568
|
0
|
|
Cash Interest Paid |
4 696
|
0
|
|
Change in Working Capital |
(3 911)
|
(7 147)
|
|
Cash from Operating Activities |
10 045
N/A
|
6 810
-32%
|
|
Investing Cash Flow | |||
Capital Expenditures |
(7 120)
|
0
|
|
Other Items |
2 780
|
3 108
|
|
Cash from Investing Activities |
(4 340)
N/A
|
(4 013)
+8%
|
|
Financing Cash Flow | |||
Net Issuance of Common Stock |
10 500
|
0
|
|
Net Issuance of Debt |
(9 886)
|
0
|
|
Cash Paid for Dividends |
0
|
0
|
|
Other |
(4 837)
|
(3 597)
|
|
Cash from Financing Activities |
(4 224)
N/A
|
(2 984)
+29%
|
|
Change in Cash | |||
Effect of Foreign Exchange Rates |
178
|
71
|
|
Net Change in Cash |
1 660
N/A
|
(116)
N/A
|
|
Free Cash Flow | |||
Free Cash Flow |
2 925
N/A
|
6 810
+133%
|